The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...

NtRON Biotechnology, Inc., a biotechnology company focused on developing innovative endolysin-based new biological drug for superbugs and unmet medical needs, today announced the strategic initiative ...

There’s no cure for genital warts, but they can be treated with a variety of methods to help manage the condition and improve ...

I had been practicing — this had been going on for two years. Until two years ago, I used to play by taking injections. We didn't know what was going on in India as we didn't know what the issue ...

As the field of artificial intelligence (AI) continues to evolve at a rapid pace, fresh research has found how techniques that render the Model Context Protocol (MCP) susceptible to prompt injection ...

Thousands of patients will benefit from a new cancer jab for more than a dozen types of the disease, with the NHS the first in Europe to offer the new injection. The health service is rolling out an ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A vial of the Phase 3 Novavax coronavirus vaccine ...

Source: AAP / Victor Joly Using the same arm for a booster vaccine as for a first dose may help the immune system respond effectively to a disease outbreak, according to new Australian research.

The improper input validation flaw allows attackers with admin access to modify firmware and run arbitrary code on affected SAN environments. A high severity flaw affecting Broadcom’s Brocade ...

However, vaccination coverage has fluctuated, especially during the coronavirus disease 2019 (COVID-19) pandemic, when healthcare disruptions and, in some countries, vaccine hesitancy created ...

Researchers headed by teams at the Garvan Institute of Medical Research and at the Kirby Institute at UNSW Sydney have discovered why receiving a vaccine booster in the same arm as the first ...

Novavax claims it can surmount the latest regulatory hurdle hindering its quest to win full U.S. clearance of its COVID-19 vaccine, saying Monday it believes its application is still approvable ...